quarterly review

Innovent, first Chinese biotech firm to market weight-loss drug, joins Hang Seng Index

3 weeks ago

0 3

Innovent Biologics will join the Hang Seng Index next month in the latest quarterly review as the compiler of the…

New World Development loses blue-chip status in ejection from Hang Seng Index

November 22, 2024

0 2

The city’s most indebted home builder joined the HSI in 1973, just a year after it went public. It was…